These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 11224489)
1. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489 [TBL] [Abstract][Full Text] [Related]
2. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study. Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058 [TBL] [Abstract][Full Text] [Related]
3. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179 [TBL] [Abstract][Full Text] [Related]
4. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265 [TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Zinzani PL; Martelli M; Bertini M; Gianni AM; Devizzi L; Federico M; Pangalis G; Michels J; Zucca E; Cantonetti M; Cortelazzo S; Wotherspoon A; Ferreri AJ; Zaja F; Lauria F; De Renzo A; Liberati MA; Falini B; Balzarotti M; Calderoni A; Zaccaria A; Gentilini P; Fattori PP; Pavone E; Angelopoulou MK; Alinari L; Brugiatelli M; Di Renzo N; Bonifazi F; Pileri SA; Cavalli F; Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899 [TBL] [Abstract][Full Text] [Related]
7. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience. Mazzarotto R; Boso C; Vianello F; Aversa MS; Chiarion-Sileni V; Trentin L; Zambello R; Muzzio PC; Fiore D; Sotti G Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):823-9. PubMed ID: 17379431 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of primary mediastinal large B-cell lymphomas]. Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753 [TBL] [Abstract][Full Text] [Related]
9. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term? Zinzani PL; Martelli M; Magagnoli M; Zaja F; Storti S; Pavone E; Lauta VM; De Renzo A; Gobbi M; Bocchia M; Ronconi F; Scaramucci L; Gherlinzoni F; Palombi F; Bendandi M; Stefoni V; Anticoli Borza P; Cellini C; Mandelli F; Tura S Haematologica; 1999 Nov; 84(11):996-1001. PubMed ID: 10553159 [TBL] [Abstract][Full Text] [Related]
10. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases]. Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196 [TBL] [Abstract][Full Text] [Related]
11. Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy. Siracusano L; Balzarotti M; Magagnoli M; Castagna L; Rahal D; Santoro A Am J Hematol; 2005 Apr; 78(4):312-3. PubMed ID: 15795908 [TBL] [Abstract][Full Text] [Related]
12. Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Zinzani PL; Bendandi M; Frezza G; Gherlinzoni F; Merla E; Salvucci M; Magagnoli M; Babini L; Tura S Leuk Lymphoma; 1996 Apr; 21(3-4):311-6. PubMed ID: 8726412 [TBL] [Abstract][Full Text] [Related]
13. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy. Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505 [TBL] [Abstract][Full Text] [Related]
14. The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients. Broccoli A; Casadei B; Stefoni V; Pellegrini C; Quirini F; Tonialini L; Morigi A; Marangon M; Argnani L; Zinzani PL BMC Cancer; 2017 Apr; 17(1):276. PubMed ID: 28415982 [TBL] [Abstract][Full Text] [Related]
15. Treatment of diffuse non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisolone and bleomycin (MACOP-B). Sawada U; Yamazaki T; Suzuki K; Ashiya M; Satou Y; Hirano H; Tsuboi I; Sakuma A; Kura Y; Kouda K Int J Hematol; 1992 Aug; 56(1):59-66. PubMed ID: 1382663 [TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. Gianni AM; Bregni M; Siena S; Brambilla C; Di Nicola M; Lombardi F; Gandola L; Tarella C; Pileri A; Ravagnani F; Valagussa P; Bonadonna G N Engl J Med; 1997 May; 336(18):1290-7. PubMed ID: 9113932 [TBL] [Abstract][Full Text] [Related]
17. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma. Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M; Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834 [TBL] [Abstract][Full Text] [Related]
18. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK; Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337 [TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal large B-cell lymphoma. Ergul SM; Lal A; Afri L; Frei-Lahr D South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098 [TBL] [Abstract][Full Text] [Related]